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to penmnce of fa&tr$ htcom#elely mversed by the left ventricular assist 
devtce or transpiaIttatiOn. 
1-1 Hypogonadlsm Contributes Significantly to the 
LOSS of Vertebwl Bone Density In Males Followlng 
Heart Transplantation 
H~s-ulrich $tempfle, Mar&a Etlinger, Chdstiane E. Angermann. 
Bnmo fvfeiser. Roland Gartner. Depfs. of Medicine, Uflivers?Y Of hkh 
Germany 
The development of accelerated osteopomsis is a recently recognized long_ 
term comptfmtfon after heart transplantation (Htx) which IS attributed t0 
direct effects of cottirxtsteroids and cycfospodne on bone mineral metabolism 
and pm&&de indirect effects via gonadal h6rrnones. The aim Of this study 
was to evaluate the ktfluence of ftypogonadism on mean vertebral bone 
density (VeD) in 50 male heart hansplants (P-HTx; 3.2 i 2.4 yrs. after HTx). 
f5e.sff parameters of cafcfum metabolism, testostemne (T). pmiactin and 
gonadotmpins were dete.mlned. VBD (m@cm) was measured by s&lie 
energy CT scan and compared between hypogonai IT < 400 ne/di) and 
nonnogonadai (T Z. 400 ngldi) P-HTx and age matched controls (C). 
Table:VBD OWk'M 
neecurst HypoBanadal Nofmqwnad% 
P.HTx G) P-HTx (Cl 
<40 - n= 5 124i33 (166f14) 
4GlS l-Is4 92127 (139f4) n= 6 lWf16 w2*43 
SO-69 n=8 95*21 (113f6) II=16 93ilS (117f71 
260 n=5 55flS ~9OflO) n- 6 77*27 (96ztt5) - 
All P-HTx had a significant reduction in VED wmpar6d to C with a further 
de&e in those with hypogonadism (17 P-HTx;34%) in eat!* age group. 
Besides hormonal status other biochemical parameters were not d&rent 
in both HTx gmups, including renal function, immunosuppression and time 
after HTx. Ail hypogonadaf P-HTx had inadequate low gonadohopin levels 
indicating hypogonadotrophic hypogonadlsm. in conclusion. hypogonadism 
contributes to bone loss in approximately one third of male patients following 
HTx, who may benefit from androgen therapy. Cyclosporfne (CyA) sdmin- 
istration is very likely the main etiologicat factor of hypcgonadism in rnaie 
P-HTx, since it has been shown in vitro that CyA inhibits testostemne biosyn- 
thesis in teydig ceils and has pmbably an additional inhibiting effect on the 
hypothaiamopituitaty axis function. 
I 996 5 Improved Resting Hemodynamics After Total vs Standard Orthotoplc Heart Transplantation I
Pstlents Wlth High Preoperative Pulmonary 
Vascular Resistance 
Ivan Aleksic. Lawrenoa SC. Czer, Dov Freimark, Johanna J.M. Takkenberg, 
Carfos Blanche, Mabeiie H. Cohen, Carmen A. Querai, Alfred0 Trento. 
Ceodrs-Sinai Medical Center, Los Angeles, CA 
Pretranspiant putronary vascular resistance (PVR) z 4 Wood units (WU) 
predisposes to rfght ventricular failure after heart transplantation. Total ortho- 
toplo heart hanspfantatfon (rOfiT) with bicaval and pulmonary venous anas- 
torttoees Offers normal anatomy & synt,hmnous contractions of the atrfa, but 
mqufres longer ischemic time than standard orfhotopic heart transplantation 
(SOHT). Methods: To test If TOHT improves resting hemodynamics in pts 
with high PreOp PVR, we followed 65 pts with SOHT and 65 with TOHT trans- 
planted between 12/&T and 7/94. Of these, 18(28%) with TOHT and 15(2%) 
with SOHT had a preop PVA 2 4 WU. Pts were selected for study if they 
had biopsy and hemodynamio data at 2 weeks and 1 year p&transplant, 
were free fmm humoral or z 18 cellular rejecfion. and did not have postop 
pacemakers, atdat fib or @-blocker therapy. 9 TOHT and 13 SOHT fulfilled 
these criteria. lschemic time was 172 f 44 vs 142 f 28 min. (p = 0.03). 
Nesulls: (p -z 0.05’ by AHOVA) (M = mean): 
co* Cl. RAW PAM’ PCWP P”FI l.la 
2wkz 
TQtiT 6.5f1.7 3.4kQ.S 6+4 22f3 llf4 l.Sfl S4*11 
SOHT 5.lfl.O 2.9i0.6 Sf5 25f7 13f7 2.511 76fl2 
1yr: 
TOHT 7.1f2.0 3.6fl.l 5f2 lSf4 9*3 1.5*0.6 99+1? 
SOHT 4.Sfl.l 2.6f0.5 7f3 25+7 14Lk.5 2.7f1.7 BOf14 
pc 0.05'byANOVAtM~mean) 
1996-7 1 Conversion From Regular Cyclosporin to 
MIcroemulsion Cyclosporin Following Heart 
Transplantation 
Alain L. Heroux. Marie-Helene LeBlanc, Danieiie Eeaudoin. Serge Simard, 
Denis A. Coulomb& Onii Gieeton, Michei D. Lemieux, Daniel P. Doyle. 
Quebec Heart fnsr%?e, Se-Fey Ouebec, CANADA; 
Rush-P~~bvterian-SLuke’s Medical Cemer, Chicago, IL 
Microemulsion cyciosporine (MCyA) is a new form of (CyA) characterized 
by impmvad absorption. To determine the effects of conversion fmm regular 
cyciosponn 4 (RCyA) to MCyA we enrolled 13 patients taking RCyA foilowing 
heart transplantation (HT) and replaced it with MCyA. There were 11 males, 
2 females aged 54.9 f 2.9 years (mean f SEM), 17.5 f 3.8 (3 to 47) months 
following HT. tnitial dose of MCyA was identical to the last RCyA dose taken 
to maintain therapeutic CyA level (180-360 ng/ml : TDX method). Serial CyA 
levels were measured over a 3 month period. Clinical, biochemical and his- 
tological assessments were done to evaluate changes from baseline. During 
follow-up (FU) : clinical side effects, renal and liver function. total, treated 
and untreated cellular rejection episodes as wail as rejection burden (sum of 
biopsy grades/months FU) did not change significantly. Serial serum choies- 
teml (CHOL) are shown in figure. During FU 9113 patients (p q 0.05) required 
introduction or increase in CHOL lowering drugs. UCyA dose decreased from 
423.1 f 27.9 to 336.5 f 24.1 mg/day (p - O.CtOil4). Cost of therapy with CyA 
decreased fmm 23.69 f 1.56 (RCyA) to 18.84 f 1.35 (MCyA) $CAN/day per 
patients. 
Conclusion: Conversion form RCvA to MCyA is safe. Majority of patients 
require treatment for early increase in serum CHOL. Cost of therapy with 
MCyA is significantly less. 
Cormlusions: In comparison wfth the standard technique. the total tech- 
ntque offers improved cardiac output and index, and lower mean RA and 
PA pressures in pts with high preop PVR. These findings may be due to 
preserved atrial synchrony. and less AV valve regurgitation, and indicate a 
lower risk of postop RV failure with the total orthotapic technique. 
